Literature DB >> 23984739

HCV infection and miravirsen.

Harry L A Janssen, Sakari Kauppinen, Michael R Hodges.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23984739     DOI： 10.1056/NEJMc1307787

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  24 in total

Review 1.  MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.

Authors:  Basak Icli; Mark W Feinberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

2.  In Vitro Silencing of lncRNAs Using LNA GapmeRs.

Authors:  Elisa Taiana; Vanessa Favasuli; Domenica Ronchetti; Eugenio Morelli; Pierfrancesco Tassone; Giuseppe Viglietto; Nikhil C Munshi; Antonino Neri; Nicola Amodio
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Chronic hepatitis C virus infection and lipoprotein metabolism.

Authors:  Yoshio Aizawa; Nobuyoshi Seki; Tomohisa Nagano; Hiroshi Abe
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 4.  HDL and microRNA therapeutics in cardiovascular disease.

Authors:  Danielle L Michell; Kasey C Vickers
Journal:  Pharmacol Ther       Date:  2016-09-03       Impact factor: 12.310

Review 5.  MicroRNAs: how many in inflammatory bowel disease?

Authors:  Jeremy S Schaefer
Journal:  Curr Opin Gastroenterol       Date:  2016-07       Impact factor: 3.287

Review 6.  Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease.

Authors:  Albert Busch; Suzanne M Eken; Lars Maegdefessel
Journal:  Ann Transl Med       Date:  2016-06

Review 7.  Playing TETris with DNA modifications.

Authors:  Benjamin Delatte; Rachel Deplus; François Fuks
Journal:  EMBO J       Date:  2014-05-13       Impact factor: 11.598

8.  Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model.

Authors:  Valeria Valsecchi; Marina Boido; Elena De Amicis; Antonio Piras; Alessandro Vercelli
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 9.  Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease.

Authors:  Swayam Prakash Srivastava; Julie E Goodwin; Pratima Tripathi; Keizo Kanasaki; Daisuke Koya
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

Review 10.  Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection.

Authors:  Mirjam B Zeisel; Emilie Crouchet; Thomas F Baumert; Catherine Schuster
Journal:  Viruses       Date:  2015-11-02       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.